[{"id":"5ede9316-e2bc-4467-ba77-03f42735b0d4","acronym":"QUILT-3.061","url":"https://clinicaltrials.gov/study/NCT04052061","created_at":"2021-01-18T19:52:05.955Z","updated_at":"2025-02-25T13:39:55.192Z","phase":"Phase 1","brief_title":"QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma","source_id_and_acronym":"NCT04052061 - QUILT-3.061","lead_sponsor":"ImmunityBio, Inc.","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19.t-haNK"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 09/16/2019","start_date":" 09/16/2019","primary_txt":" Primary completion: 09/18/2021","primary_completion_date":" 09/18/2021","study_txt":" Completion: 08/19/2022","study_completion_date":" 08/19/2022","last_update_posted":"2025-02-21"}]